In PC mouse models, the combination of nitroxoline and PD-1 blockade increased the number of CD44+/CD62L+/CD8+ memory T cells and reduced the number of MDSCs in peripheral blood, apparently providing synergistic antitumor immunity. This evidence concerns the gene CD8A and pachyonychia congenita.